2021 AISF_SIN意见书:肝肾疾病

2021-06-01 意大利肝病学会 Dig Liver Dis.2021 Jun;53 Suppl 2:S49-S86.

2021年6月,意大利肝病学会(AISF)联合意大利肾病学会(SIN)共同发布了肝肾疾病意见书。在生理和病理情况下,肝脏和肾脏是以相互作用的方式紧密相连的。本文主要介绍了肝肾疾病之间相关性的最新概况。

中文标题:

2021 AISF_SIN意见书:肝肾疾病

英文标题:

Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN)

发布机构:

意大利肝病学会

发布日期:

2021-06-01

简要介绍:

2021年6月,意大利肝病学会(AISF)联合意大利肾病学会(SIN)共同发布了肝肾疾病意见书。在生理和病理情况下,肝脏和肾脏是以相互作用的方式紧密相连的。本文主要介绍了肝肾疾病之间相关性的最新概况。内容涉及慢性肝病患者肾脏损伤的诊断,肝硬化急性肾损伤,慢性肝病与慢性肾病的关系,不同病因的肝病对于肾脏的损害,多囊肾病和肝病。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 AISF_SIN意见书:肝肾疾病.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cac521c00211a204, title=2021 AISF_SIN意见书:肝肾疾病, enTitle=Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN), guiderFrom=Dig Liver Dis.2021 Jun;53 Suppl 2:S49-S86., authorId=0, author=, summary=2021年6月,意大利肝病学会(AISF)联合意大利肾病学会(SIN)共同发布了肝肾疾病意见书。在生理和病理情况下,肝脏和肾脏是以相互作用的方式紧密相连的。本文主要介绍了肝肾疾病之间相关性的最新概况。, cover=https://img.medsci.cn/2021623/1624435471488_2020535.jpg, journalId=0, articlesId=null, associationId=487, associationName=意大利肝病学会, associationIntro=意大利肝病学会致力于肝病研究,官方杂志《Digestive and Liver Disease》, copyright=0, guiderPublishedTime=Tue Jun 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年6月,意大利肝病学会(AISF)联合意大利肾病学会(SIN)共同发布了肝肾疾病意见书。在生理和病理情况下,肝脏和肾脏是以相互作用的方式紧密相连的。本文主要介绍了肝肾疾病之间相关性的最新概况。内容涉及慢性肝病患者肾脏损伤的诊断,肝硬化急性肾损伤,慢性肝病与慢性肾病的关系,不同病因的肝病对于肾脏的损害,多囊肾病和肝病。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=113039, tagName=肝肾疾病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=6634, guiderKeyword=肝脏疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=16052, appHits=92, showAppHits=0, pcHits=358, showPcHits=15960, likes=0, shares=4, comments=5, approvalStatus=1, publishedTime=Wed Jun 23 17:23:35 CST 2021, publishedTimeString=2021-06-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 23 16:04:41 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Tue Jan 02 21:51:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AISF_SIN意见书:肝肾疾病.pdf)])
2021 AISF_SIN意见书:肝肾疾病.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错,好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-10-15 鸿毳沉舟

    有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错,好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-09-16 936368183

    不错,好用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错,好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-09-10 ms5000001604660080

    收藏

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错,好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-07-12 一缕阳光 Lee

    很好,实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1060684, encodeId=2b9f106068486, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Fri Oct 15 10:24:47 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052079, encodeId=3c4610520e988, content=不错,好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6274853329, createdName=936368183, createdTime=Thu Sep 16 20:21:32 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016265, encodeId=92541016265d1, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e975535785, createdName=ms5000001604660080, createdTime=Fri Sep 10 09:46:31 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998903, encodeId=0a7b99890360, content=很好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=988d5417384, createdName=一缕阳光 Lee, createdTime=Mon Jul 12 21:55:09 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977875, encodeId=58d99e787589, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:30:04 CST 2021, time=2021-06-29, status=1, ipAttribution=)]
    2021-06-29 李曌

    0

拓展阅读

2016 ACG临床指南:肝脏疾病与妊娠

美国胃肠病学院(ACG,American College of Gastroenterology) · 2016-03-14

2015年意大利肝病协会(AISF)意见书:肝脏疾病与妊娠

意大利肝病学会(AISF,Italian Association for the Study of the Liver) · 2016-06-08

2016年美国胃肠病学院临床指南:肝脏疾病与妊娠(中文)

美国胃肠病学院(ACG,American College of Gastroenterology) · 2016-06-08

肝脏局灶性病变CT和MRI标注专家共识(2020)

中华医学会放射学分会(CSR,chinese society of radiology) · 2020-12-20

2021 EASL实践指南:肝脏疾病严重程度及预后的无创检测(更新版)

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2021-06-03

《APASL慢性乙型肝炎患者停用核苷(酸)类似物指导意见》解读

国家重大公共卫生事件医学中心华中科技大学同济医学院附属同济医院感染科 · 2021-10-20